Changes in IL-6, YKL40 and VEGF during adalimumab treatment in patients with active rheumatoid arthritis

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Changes in IL-6, YKL40 and VEGF during adalimumab treatment in patients with active rheumatoid arthritis. / Knudsen, L.S.; Johansen, J.S.; Dohn, U.M.; Hetland, M.L.; Boonen, A.; Hansen, M.S.; Hansen, A.; Madsen, Ole Rintek; Hasselquist, M.; Moller, J.M.; Ostergaard, M.

In: Arthritis & Rheumatism, Vol. 58, No. 9 Suppl. S., 2008, p. S552-S553.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Knudsen, LS, Johansen, JS, Dohn, UM, Hetland, ML, Boonen, A, Hansen, MS, Hansen, A, Madsen, OR, Hasselquist, M, Moller, JM & Ostergaard, M 2008, 'Changes in IL-6, YKL40 and VEGF during adalimumab treatment in patients with active rheumatoid arthritis', Arthritis & Rheumatism, vol. 58, no. 9 Suppl. S., pp. S552-S553.

APA

Knudsen, L. S., Johansen, J. S., Dohn, U. M., Hetland, M. L., Boonen, A., Hansen, M. S., Hansen, A., Madsen, O. R., Hasselquist, M., Moller, J. M., & Ostergaard, M. (2008). Changes in IL-6, YKL40 and VEGF during adalimumab treatment in patients with active rheumatoid arthritis. Arthritis & Rheumatism, 58(9 Suppl. S.), S552-S553.

Vancouver

Knudsen LS, Johansen JS, Dohn UM, Hetland ML, Boonen A, Hansen MS et al. Changes in IL-6, YKL40 and VEGF during adalimumab treatment in patients with active rheumatoid arthritis. Arthritis & Rheumatism. 2008;58(9 Suppl. S.):S552-S553.

Author

Knudsen, L.S. ; Johansen, J.S. ; Dohn, U.M. ; Hetland, M.L. ; Boonen, A. ; Hansen, M.S. ; Hansen, A. ; Madsen, Ole Rintek ; Hasselquist, M. ; Moller, J.M. ; Ostergaard, M. / Changes in IL-6, YKL40 and VEGF during adalimumab treatment in patients with active rheumatoid arthritis. In: Arthritis & Rheumatism. 2008 ; Vol. 58, No. 9 Suppl. S. pp. S552-S553.

Bibtex

@article{a49f472001af11deb05e000ea68e967b,
title = "Changes in IL-6, YKL40 and VEGF during adalimumab treatment in patients with active rheumatoid arthritis",
abstract = "Udgivelsesdato: 2008/9",
author = "L.S. Knudsen and J.S. Johansen and U.M. Dohn and M.L. Hetland and A. Boonen and M.S. Hansen and A. Hansen and Madsen, {Ole Rintek} and M. Hasselquist and J.M. Moller and M. Ostergaard",
year = "2008",
language = "English",
volume = "58",
pages = "S552--S553",
journal = "Arthritis & Rheumatology",
issn = "2326-5205",
publisher = "Wiley",
number = "9 Suppl. S.",

}

RIS

TY - JOUR

T1 - Changes in IL-6, YKL40 and VEGF during adalimumab treatment in patients with active rheumatoid arthritis

AU - Knudsen, L.S.

AU - Johansen, J.S.

AU - Dohn, U.M.

AU - Hetland, M.L.

AU - Boonen, A.

AU - Hansen, M.S.

AU - Hansen, A.

AU - Madsen, Ole Rintek

AU - Hasselquist, M.

AU - Moller, J.M.

AU - Ostergaard, M.

PY - 2008

Y1 - 2008

N2 - Udgivelsesdato: 2008/9

AB - Udgivelsesdato: 2008/9

M3 - Journal article

VL - 58

SP - S552-S553

JO - Arthritis & Rheumatology

JF - Arthritis & Rheumatology

SN - 2326-5205

IS - 9 Suppl. S.

ER -

ID: 10733332